Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality

Vincenzo Livio Malavasi; E Fantecchi; Laura Gianolio; Francesca Pesce; Giuseppe Longo; Marco Marietta; Stefano Cascinu; Professor Gregory Lip; Giuseppe Boriani

doi:10.1016/j.ejim.2018.10.012

Related publications

Article2022

612 EVOLUTION OF ATRIAL FIBRILLATION PATTERNS AND IMPACT ON ALL-CAUSE MORTALITY IN A CONTEMPORARY COHORT OF EUROPEAN PATIENTS WITH ATRIAL FIBRILLATION

Marco Vitolo, Niccolò Bonini, Jacopo Francesco Imberti, Davide Antonio Mei, Nicola Forzati, Vera Laus, Marco Stuani, Francesco Chiriaco, Matteo Menozzi, Giulio Francesco Romiti, Marco Proietti, Vincenzo Livio Malavasi, Professor Gregory Lip, Giuseppe Boriani

Article2023

Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients

Marco Vitolo, Marco Proietti, Jacopo Francesco Imberti, Niccolò Bonini, Giulio Francesco Romiti, Davide Antonio Mei, Vincenzo Livio Malavasi, Igor Diemberger, Laurent Fauchier, Francisco Marı́n, Michael Näbauer, Tatjana Potpara, Gheorghe‐Andrei Dan, Professor Gregory Lip, Giuseppe Boriani

Article2021

Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality

Discussion(0)

Related publications

612 EVOLUTION OF ATRIAL FIBRILLATION PATTERNS AND IMPACT ON ALL-CAUSE MORTALITY IN A CONTEMPORARY COHORT OF EUROPEAN PATIENTS WITH ATRIAL FIBRILLATION

Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients

Exercise‐Based Cardiac Rehabilitation and All‐Cause Mortality Among Patients With Atrial Fibrillation

Associations of exercise-based cardiac rehabilitation with all-cause mortality among patients with atrial fibrillation

Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction